Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

A single center, open-label trial of isavuconazole prophylaxis against invasive fungal infection in patients undergoing allogeneic hematopoietic cell transplant (HCT)

(2020) Anat Stern et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm

(2020) Shuk Ying Chan et al.   MEDICAL MYCOLOGY

Real‐world use—Isavuconazole at a large academic medical center

(2019) Habiba Hassouna et al.   MYCOSES

Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

(2019) Lauren Fontana et al.   CLINICAL INFECTIOUS DISEASES

Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre

(2019) Christina D. Bowen et al.   MYCOSES

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

(2019) Stefan Schwartz et al.   MEDICAL MYCOLOGY

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

(2018) Johan Maertens et al.   MYCOSES

Tolerability of isavuconazole after posaconazole toxicity in leukemia patients

(2018) Adam J DiPippo et al.   MYCOSES

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

(2018) Bart Jan Kullberg et al.   CLINICAL INFECTIOUS DISEASES

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial

(2017) Dimitrios P Kontoyiannis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation

(2016) G S Hobbs et al.   BONE MARROW TRANSPLANTATION

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study

(2014) Susan K. Seo et al.   JOURNAL OF INFECTION

Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant

(2014) Izaskun Ceberio et al.   LEUKEMIA & LYMPHOMA

Serious Infection Risk and Immune Recovery after Double-Unit Cord Blood Transplantation Without Antithymocyte Globulin

(2011) Craig Sauter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

(2010) J. R. Wingard et al.   BLOOD

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

(2009) Marcie Tomblyn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) I. Amigues et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES